-
1تقرير
المصدر: A Phase 1/2 Study of [225Ac]-FPI-1966, [111In]-FPI-1967, and Vofatamab in Participants With FGFR3-expressing Advanced, Inoperable, Metastatic and/or Recurrent Solid Tumours
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05363605Test
Other URLs: http://fusionpharma.comTest
-
2تقرير
المصدر: A Phase 1/2a, Open-Label, Multi-Center Study Evaluating the Safety and Anti-Tumor Activity of Ex Vivo Expanded, Autologous Natural Killer Cells (SNK01) in Combination With Trastuzumab or Cetuximab in Subjects With Advanced/Metastatic HER2- or EGFR-Expressing Cancers
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04464967Test
